107 related articles for article (PubMed ID: 24933334)
1. Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice.
Kale PP; Addepalli V
Pharmacol Biochem Behav; 2014 Sep; 124():238-44. PubMed ID: 24933334
[TBL] [Abstract][Full Text] [Related]
2. The effect of bupropion augmentation of minocycline in the treatment of depression.
Bendale M; DSouza SR; Addepalli V; Kale PP
Acta Neurobiol Exp (Wars); 2019; 79(2):217-224. PubMed ID: 31342957
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice.
Nadar JS; Kale PP; Kadu PK; Prabhavalkar K; Dhangar R
Neurol Res Int; 2018; 2018():9828639. PubMed ID: 30510800
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of nootropic effect of duloxetine and bupropion by caffeine in mice.
Kale PP; Addepalli V
Indian J Pharmacol; 2015; 47(2):199-201. PubMed ID: 25878382
[TBL] [Abstract][Full Text] [Related]
5. The influence of caffeine on the activity of moclobemide, venlafaxine, bupropion and milnacipran in the forced swim test in mice.
Poleszak E; Szopa A; Wyska E; Wośko S; Serefko A; Wlaź A; Pieróg M; Wróbel A; Wlaź P
Life Sci; 2015 Sep; 136():13-8. PubMed ID: 26135623
[TBL] [Abstract][Full Text] [Related]
6. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
Fuller RW; Hemrick-Luecke SK; Snoddy HD
J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
[TBL] [Abstract][Full Text] [Related]
7. The role of the NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of duloxetine in the forced swimming test.
Zomkowski AD; Engel D; Cunha MP; Gabilan NH; Rodrigues AL
Pharmacol Biochem Behav; 2012 Dec; 103(2):408-17. PubMed ID: 23010381
[TBL] [Abstract][Full Text] [Related]
8. Influence of sildenafil on the antidepressant activity of bupropion and venlafaxine in the forced swim test in mice.
Socała K; Nieoczym D; Wyska E; Poleszak E; Wlaź P
Pharmacol Biochem Behav; 2012 Dec; 103(2):273-8. PubMed ID: 22940586
[TBL] [Abstract][Full Text] [Related]
9. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
Dhir A; Kulkarni SK
Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
[TBL] [Abstract][Full Text] [Related]
10. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
11. Evidences for the agmatine involvement in antidepressant like effect of bupropion in mouse forced swim test.
Kotagale NR; Tripathi SJ; Aglawe MM; Chopde CT; Umekar MJ; Taksande BG
Pharmacol Biochem Behav; 2013 Jun; 107():42-7. PubMed ID: 23583442
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine-bupropion combination for treatment-resistant atypical depression: a double-blind, randomized, placebo-controlled trial.
Fornaro M; Martino M; Mattei C; Prestia D; Vinciguerra V; De Berardis D; De Pasquale C; Iasevoli F; Mungo S; Fornaro P
Eur Neuropsychopharmacol; 2014 Aug; 24(8):1269-78. PubMed ID: 24842649
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice.
Wang QS; Ding SL; Mao HP; Cui YL; Qi XJ
J Ethnopharmacol; 2013 Jul; 148(2):603-9. PubMed ID: 23702040
[TBL] [Abstract][Full Text] [Related]
14. Bupropion: a review of its mechanism of antidepressant activity.
Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the dopaminergic and serotonergic systems in the antidepressant-like effect caused by 4-phenyl-1-(phenylselanylmethyl)-1,2,3-triazole.
Donato F; de Gomes MG; Goes AT; Seus N; Alves D; Jesse CR; Savegnago L
Life Sci; 2013 Sep; 93(9-11):393-400. PubMed ID: 23911670
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
[TBL] [Abstract][Full Text] [Related]
17. Effect of a combination of duloxetine with hydroxyzine on experimental models of anxiety in mice.
Patel S; Kale PP; Addepalli V; Sarkar A; Savai J
Indian J Pharmacol; 2015; 47(2):173-6. PubMed ID: 25878376
[TBL] [Abstract][Full Text] [Related]
18. Chronic administration of duloxetine and mirtazapine downregulates proapoptotic proteins and upregulates neurotrophin gene expression in the hippocampus and cerebral cortex of mice.
Engel D; Zomkowski AD; Lieberknecht V; Rodrigues AL; Gabilan NH
J Psychiatr Res; 2013 Jun; 47(6):802-8. PubMed ID: 23522402
[TBL] [Abstract][Full Text] [Related]
19. The β4 nicotinic receptor subunit modulates the chronic antidepressant effect mediated by bupropion.
Radhakrishnan R; Santamaría A; Escobar L; Arias HR
Neurosci Lett; 2013 Oct; 555():68-72. PubMed ID: 23981664
[TBL] [Abstract][Full Text] [Related]
20. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.
Papakostas GI; Worthington JJ; Iosifescu DV; Kinrys G; Burns AM; Fisher LB; Homberger CH; Mischoulon D; Fava M
Depress Anxiety; 2006; 23(3):178-81. PubMed ID: 16528701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
